{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:33:26Z","timestamp":1761676406606},"reference-count":47,"publisher":"Baishideng Publishing Group Inc.","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJSC"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4252\/wjsc.v8.i7.223","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T06:07:25Z","timestamp":1468562845000},"page":"223","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus"],"prefix":"10.4252","volume":"8","author":[{"given":"Geeta","family":"Shroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/628591"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1691"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.14"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-015-2140-9"},{"key":"ref5","unstructured":"Barclay RS. Type 2 diabetes is common and hard to treat. Now, a cure may be on the horizon. Healthline News. 2015; Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.healthline.com\/health-news\/combination-of-stem-cell-drug-therapy-could-reverse-type 2-diabetes-051915\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.healthline.com\/health-news\/combination-of-stem-cell-drug-therapy-could-reverse-type 2-diabetes-051915<\/ext-link>."},{"key":"ref6","unstructured":"National Institutes of Health. Stem cells and diabetes. Bethesda, USA, 2001. [accessed Oct 15]. 2015; Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/stemcells.Nih.Gov\/info\/scireport\/pages\/chapter7.Aspx\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/stemcells.Nih.Gov\/info\/scireport\/pages\/chapter7.Aspx<\/ext-link>."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01957.x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.138"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314474"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00092.x"},{"key":"ref12","unstructured":"Mazzola N. Review of current and emerging therapies in type 2 diabetes mellitus. Am J Manag Care 2012;18:S17-S26."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.021857"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ15-0186"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1711"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31819c86ea"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.8.4151"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102198"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5348\/ijcri-201503-CS-10054"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5214\/ans.0972.7531.220404"},{"key":"ref21","unstructured":"Shroff G. Establishment and characterization of neuronal cell line derived from a 2-cell stage human embryo. Int J Recent Sci Res 2015;6:3730-3738."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0318-7"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7013.1000189"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011-1017.","DOI":"10.1016\/S0015-0282(16)57066-6"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-44"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4236\/jdm.2015.54030"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2008.01.004"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO. Managing type 2 diabetes: going beyond glycemic control. J Manag Care Pharm 2008;14:s2-19.","DOI":"10.18553\/jmcp.2008.14.S5-B.1"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17375"},{"key":"ref30","unstructured":"Weir G. Do stem cells hold the key to a future cure for diabetes? Diabetes Voice 2008; Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.idf.org\/diabetesvoice\/articles\/do-stem-cells-hold-the-key-to-a-future-cure-for-diabetes\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.idf.org\/diabetesvoice\/articles\/do-stem-cells-hold-the-key-to-a-future-cure-for-diabetes<\/ext-link>."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.22-4-448"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2005-0188"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/1570161111309010100"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mishra PK, Singh SR, Joshua IG, Tyagi SC. Stem cells as a therapeutic target for diabetes. Front Biosci (Landmark Ed) 2010;15:461-477.","DOI":"10.2741\/3630"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2174\/1566524011307010109"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.2.157"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/1534734614534977"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2006005000166"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/194858"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2009.0164"},{"key":"ref42","unstructured":"Stem cell therapy for type 2 diabetes mellitus. 2010. ClinicalTrials.gov Identifier: NCT01142050. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01142050?rank=6&amp;term=stem%20cells%20and%20diabetes%20type%202\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01142050?rank=6&amp;term=stem%20cells%20and%20diabetes%20type%202<\/ext-link>."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00086"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.144"},{"key":"ref45","unstructured":"Mack R, Skurnick B, Sterling-Jean Y, Pedra-Nobre M, Bigg D. Fasting insulin levels as a measure of insulin resistance in American blacks. J Med 2003;34:31-38."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(99)00109-6"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.27.4.132"}],"container-title":["World Journal of Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-0210\/full\/v8\/i7\/223.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T05:37:01Z","timestamp":1568180221000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-0210\/full\/v8\/i7\/223.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4252\/wjsc.v8.i7.223","relation":{},"ISSN":["1948-0210"],"issn-type":[{"value":"1948-0210","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}